Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Open in API
Filings indexed 480 across all filing types
Latest filing 2019-01-02 Major Shareholding Noti…
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 9325L' and the closing statement confirms it is provided by RNS, the news service of the London Stock Exchange, approved by the FCA. The content is a 'TR-1: Standard form for notification of major holdings,' which details changes in share ownership thresholds (crossing from 5.03% to 4.98%). This type of mandatory disclosure regarding significant shareholdings falls under regulations concerning major shareholding notifications. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2019-01-02 English
Annual Report and Accounts 2019
Annual Report
2018-12-31 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is explicitly identified as an 'RNS Number' filing from ConvaTec Group Plc, dated December 18, 2018. The content details a 'Director/PDMR Shareholding' transaction involving the Chief Financial Officer, Frank Schulkes, specifically the grant of a conditional share award under the LTIP. This type of mandatory disclosure regarding insider transactions by persons discharging managerial responsibilities (PDMRs) is a specific regulatory filing. Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate fit for reporting personal share transactions by directors and executives. Although it is distributed via RNS, the core subject matter is DIRS.
2018-12-18 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is explicitly labeled with an 'RNS Number' and states that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content details the 'Total Voting Rights' as of a specific date (31 October 2018) and provides the total number of shares, which is a mandatory regulatory disclosure under the UK FCA's Disclosure and Transparency Rule 5.6.1. This type of general regulatory announcement that doesn't fit into specific categories like Director's Dealing (DIRS) or Major Shareholding Notification (MRQ) is best classified as a general Regulatory Filing (RNS). The document length is short (2612 chars), but it is a direct disclosure, not an announcement *about* another report.
2018-11-01 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document text explicitly contains the header 'RNS Number : 3801F' and the form title 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in major shareholdings (crossing notification thresholds) as required by regulatory bodies (like the FCA mentioned). This directly corresponds to the definition for Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific category for this type of regulatory disclosure.
2018-10-26 English
ConvaTec Receives FDA 510(k) Clearance for Avelle
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated October 26, 2018. The content announces that ConvaTec received U.S. FDA 510(k) clearance for a new medical device (Avelle™ NPWT system). This is a specific, material announcement made to the market via the Regulatory News Service (RNS) system, which is the primary information provider for the London Stock Exchange. Since it is a specific regulatory announcement that doesn't fit into defined categories like Earnings Release (ER), Director's Dealing (DIRS), or Capital Change (CAP), it falls best under the general regulatory announcement category, RNS, as per the provided definitions and the presence of the RNS identifier.
2018-10-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.